GENPHARMASEC LIMITEDGENPHARMASEC LIMITEDGENPHARMASEC LIMITED

GENPHARMASEC LIMITED

No trades
See on Supercharts
Market capitalization
‪1.72 B‬INR
0.00INR
‪−1.26 M‬INR
‪304.06 M‬INR
Beta (1Y)
1.71
Employees (FY)
10
Change (1Y)
+1 +11.11%
Revenue / Employee (1Y)
‪364.53 K‬INR
Net income / Employee (1Y)
‪−1.51 K‬INR

About GENPHARMASEC LIMITED


Headquarters
Mumbai
Founded
1992
ISIN
INE861N01036
FIGI
BBG000C08J78
Genpharmasec Ltd. engages in pharmaceutical activities, services, and trading in equity shares. It operates through Distribution of Diagnostic Equipment's and Investment and Trading in Securities segments. The company was founded on November 16, 1992 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GENPHARMA is 3.02 INR — it has decreased by −2.58% in the past 24 hours. Watch GENPHARMASEC LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GENPHARMASEC LIMITED stocks are traded under the ticker GENPHARMA.
GENPHARMA stock has fallen by −8.48% compared to the previous week, the month change is a 3.78% rise, over the last year GENPHARMASEC LIMITED has showed a 17.51% increase.
GENPHARMA reached its all-time high on Oct 26, 2011 with the price of 57.64 INR, and its all-time low was 0.75 INR and was reached on Dec 20, 2016. View more price dynamics on GENPHARMA chart.
See other stocks reaching their highest and lowest prices.
GENPHARMA stock is 4.67% volatile and has beta coefficient of 1.71. Track GENPHARMASEC LIMITED stock price on the chart and check out the list of the most volatile stocks — is GENPHARMASEC LIMITED there?
Today GENPHARMASEC LIMITED has the market capitalization of ‪1.67 B‬, it has increased by 10.29% over the last week.
Yes, you can track GENPHARMASEC LIMITED financials in yearly and quarterly reports right on TradingView.
GENPHARMA net income for the last quarter is ‪2.87 M‬ INR, while the quarter before that showed ‪−2.24 M‬ INR of net income which accounts for 228.15% change. Track more GENPHARMASEC LIMITED financial stats to get the full picture.
No, GENPHARMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 10.00 employees. See our rating of the largest employees — is GENPHARMASEC LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENPHARMASEC LIMITED EBITDA is ‪1.39 M‬ INR, and current EBITDA margin is 0.15%. See more stats in GENPHARMASEC LIMITED financial statements.
Like other stocks, GENPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENPHARMASEC LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENPHARMASEC LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENPHARMASEC LIMITED stock shows the neutral signal. See more of GENPHARMASEC LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.